Solenis Acquires Diversey for $4.6 Billion

Solenis, a specialty chemicals manufacturer for water-intensive industries, has completed its acquisition of Diversey, a hygiene and cleaning products provider, in an all-cash transaction valued at ~ $4.6 billion.

With this acquisition, Solenis now operates in over 130 countries with 71 manufacturing facilities and over 15,000 employees.

“We now have greatly enhanced capabilities to help our customers tackle critical sustainability challenges, reduce their environmental impact and help create a cleaner, safer world,” said John Panichella, CEO, Solenis.

Solenis has been owned by Platinum Equity since its acquisition in 2021. The majority shareholder of Diversey, Bain Capital, will now be a minority stakeholder in Solenis after the merger. 

Solenis and Diversey unite in $4.6 billion acquisition. © Solenis
Solenis and Diversey unite in $4.6 billion acquisition. © Solenis

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.